EP3813822A4 - Solid oral pharmaceutical compositions comprising teriflunomide - Google Patents

Solid oral pharmaceutical compositions comprising teriflunomide Download PDF

Info

Publication number
EP3813822A4
EP3813822A4 EP19824639.9A EP19824639A EP3813822A4 EP 3813822 A4 EP3813822 A4 EP 3813822A4 EP 19824639 A EP19824639 A EP 19824639A EP 3813822 A4 EP3813822 A4 EP 3813822A4
Authority
EP
European Patent Office
Prior art keywords
teriflunomide
pharmaceutical compositions
solid oral
oral pharmaceutical
solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19824639.9A
Other languages
German (de)
French (fr)
Other versions
EP3813822A2 (en
Inventor
Ali Turkyilmaz
Ediz Yildirim
Bulent DEMIR
Ibrahim ATMACA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP3813822A2 publication Critical patent/EP3813822A2/en
Publication of EP3813822A4 publication Critical patent/EP3813822A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP19824639.9A 2018-06-27 2019-06-24 Solid oral pharmaceutical compositions comprising teriflunomide Pending EP3813822A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR201809045 2018-06-27
PCT/TR2019/050497 WO2020005189A2 (en) 2018-06-27 2019-06-24 Solid oral pharmaceutical compositions comprising teriflunomide

Publications (2)

Publication Number Publication Date
EP3813822A2 EP3813822A2 (en) 2021-05-05
EP3813822A4 true EP3813822A4 (en) 2022-03-16

Family

ID=68987306

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19824639.9A Pending EP3813822A4 (en) 2018-06-27 2019-06-24 Solid oral pharmaceutical compositions comprising teriflunomide

Country Status (2)

Country Link
EP (1) EP3813822A4 (en)
WO (1) WO2020005189A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022085015A1 (en) * 2020-10-24 2022-04-28 V-Ensure Pharma Technologies Private Limited A solid oral composition of teriflunomide
TR202022336A2 (en) * 2020-12-30 2022-07-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A FILM COATED TABLET COMPRISING TERIFLUNOOMIDE
EP4382097A1 (en) * 2022-11-25 2024-06-12 Sanovel Ilac Sanayi Ve Ticaret A.S. A tablet comprising teriflunomide

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015077535A2 (en) * 2013-11-22 2015-05-28 Genzyme Corporation Novel methods for treating neurodegenerative diseases
WO2016079687A1 (en) * 2014-11-18 2016-05-26 Lupin Limited Oral pharmaceutical composition of teriflunomide
WO2016189406A1 (en) * 2015-05-23 2016-12-01 Ftf Pharma Private Limited Pharmaceutical composition of teriflunomide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2496486C1 (en) * 2012-07-11 2013-10-27 Александр Васильевич Иващенко Pharmaceutical composition exhibiting improved flowability, drug preparation, method for preparing and using
WO2017037645A1 (en) * 2015-09-02 2017-03-09 Leiutis Pharmaceuticals Pvt Ltd Stable pharmaceutical formulations of teriflunomide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015077535A2 (en) * 2013-11-22 2015-05-28 Genzyme Corporation Novel methods for treating neurodegenerative diseases
WO2016079687A1 (en) * 2014-11-18 2016-05-26 Lupin Limited Oral pharmaceutical composition of teriflunomide
WO2016189406A1 (en) * 2015-05-23 2016-12-01 Ftf Pharma Private Limited Pharmaceutical composition of teriflunomide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020005189A2 *

Also Published As

Publication number Publication date
EP3813822A2 (en) 2021-05-05
WO2020005189A2 (en) 2020-01-02
WO2020005189A3 (en) 2020-03-12

Similar Documents

Publication Publication Date Title
EP3817722A4 (en) Pharmaceutical compositions comprising meloxicam
EP4045480A4 (en) Pharmaceutical formulations
EP3781135A4 (en) Solid oral pharmaceutical compositions comprising sitagliptin
IL285674A (en) Pharmaceutical formulations
EP3851121A4 (en) Human anti-il-33 monoclonal-antibody-containing pharmaceutical composition
EP3868371A4 (en) Novel pharmaceutical composition
EP3746078A4 (en) Oral formulations and uses thereof
EP3813822A4 (en) Solid oral pharmaceutical compositions comprising teriflunomide
IL290469A (en) Oral pharmaceutical composition
EP3895682A4 (en) Dental composition
EP3801539A4 (en) Solid oral pharmaceutical compositions of linagliptin
EP3756471A4 (en) Oral ingestion composition
EP3796915A4 (en) Oral formulations comprising rivaroxaban
EP3881841A4 (en) Pharmaceutical composition
EP3817744A4 (en) Ivosidenib forms and pharmaceutical compositions
EP3746080A4 (en) Pharmaceutical formulations
EP3805210A4 (en) Novel compound and pharmaceutical composition comprising same
EP3858322A4 (en) Dental composition
EP4032535A4 (en) Pharmaceutical composition
EP4081251A4 (en) Pharmaceutical compositions
EP3984549A4 (en) Medicinal composition
EP3914234A4 (en) Pharmaceutical compositions
EP3949952A4 (en) Medicinal composition
EP3920909A4 (en) Pharmaceutical compositions comprising meloxicam
EP3811787A4 (en) Oral composition

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201225

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220216

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/20 20060101ALI20220210BHEP

Ipc: A61K 9/28 20060101ALI20220210BHEP

Ipc: A61K 47/10 20170101ALI20220210BHEP

Ipc: A61K 31/277 20060101AFI20220210BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230708

17Q First examination report despatched

Effective date: 20230725